News

Medtronic plc, the global leader in medical technology, announced that the primary results of the Medtronic-sponsored STOP AF First clinical trial have been published in the New England Journal of Medicine (NEJM). Results from the trial...

TRANSLATE-HF study establishes the potential for broad use of the only SGLT2 inhibitor indicated in patients with heart failure with reduced ejection fraction with and without diabetes New data from a large, contemporary U.S. hospitalized...

Series-E Round led by existing investors OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures and Bold Capital AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, announced...

Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the intelligent Continuous Lesion Ablation System (iCLAS™), announced that it has closed a $42.5...

Taking omega-3 fatty acids and vitamin D3 supplements does not neither increase nor decrease the risk of developing atrial fibrillation, according to late-breaking research presented at the American Heart Association's Scientific Sessions...

Acutus Medical announced the appointment of Steven Mickelsen, MD, as Chief Translational Science Officer. Dr. Mickelsen will help guide the company’s vision to deliver the most advanced electrophysiology therapeutic solutions on the market...

Two ZOLL Products Named 2020 New Products of the Year by Occupational Health & Safety Magazine ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that two new...

With its newly-approved CE Mark, Denver-based company HeartHero is poised on the front lines to combat the global threat of cardiac death. Created by a team of medical experts and partners, Elliot’s affordable price tag and portable size...

Eko wants every patient with chronic cardiovascular disease to be one click away from their doctor Eko, a cardiopulmonary digital health company, announced $65 million in Series C funding led by Highland Capital Partners and Questa Capital,...

Former President and Chief Executive Officer of Cleveland Clinic to advance company's leadership in cardiological care AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced the appointment of...